EUVIMEDEUVIMED entdecken
Crossref

Does preoperative corticosteroid injection increase the risk of periprosthetic joint infection after reverse shoulder arthroplasty?

Nayeem Baksh, Vidushan Nadarajah, Katherine M Connors, Sandeep S Bains, Zhongming Chen, Jeremy A Dubin, Qais Naziri

Journal of Shoulder and Elbow Surgery · 2023

DOI: 10.1016/j.jse.2023.01.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Shoulder and Elbow Surgery, 2023. Verfasst von Nayeem Baksh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery and Rehabilitation Medicine, Downstate Medical Center, State University of New York (SUNY), Brooklyn, NY, USA. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Arthroplasty, Replacement, Shoulder, Arthritis, Infectious, Osteoarthritis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Corticosteroid injections (CSIs) are used for the symptomatic management of osteoarthritis. However, their use may contaminate the joint space and pose an increased risk of periprosthetic joint infection (PJI) following reverse shoulder arthroplasty (RSA). Therefore, the purpose of this study was to assess whether there is any association between the timing of CSI and the incidence of PJI at 90 days, 1 year, and 2 years postoperatively. Specifically, we assessed the risk of PJI in patients who received CSI 3 months prior to RSA, as well as associated risk factors for PJI with CSI. METHODS: We queried a national, all-payer database to identify patients who underwent RSA from October 1, 2015, to October 31, 2020 (1.5 million patients). Patients who received an osteoarthritis diagnosis prior to RSA were selected, whereas those with bilateral RSA or >1 injection on the same side were excluded. This resulted in 5 cohorts: cohort receiving CSI within 4 weeks of RSA (n = 5607), cohort receiving CSI 1-2 months prior to RSA (n = 3024), cohort receiving CSI 2-3 months prior to RSA (n = 1572), cohort receiving CSI >3 months prior to RSA (n = 16,302), and control cohort with no injection prior to RSA (n = 21,938). Bivariate χ2 analyses of outcomes were conducted, in addition to multivariate regressions performed to adjust for comorbidities, as well as to assess associated risk factors. RESULTS: The adjusted analyses demonstrated a significantly increased risk of PJI at 90 days in patients who received CSI within 1 month of RSA (P 1 month before RSA (all P ≥ .088). Furthermore, alcohol abuse, chronic kidney disease, and depression were identified as risk factors that increased the risk of PJI. CONCLUSION: Intra-articular shoulder CSIs

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsArthroplasty, Replacement, ShoulderArthritis, InfectiousOsteoarthritisShoulder JointHumansArthroplastyAdrenal Cortex HormonesRetrospective Studies

Stichwörter der Autor:innen

Corticosteroid injectionscomplicationsintra-articular shoulder injectionsosteoarthritisperiprosthetic joint infectionreverse shoulder arthroplasty

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery and Rehabilitation Medicine, Downstate Medical Center, State University of New York (SUNY), Brooklyn, NY, USA.
  • Lifebridge Health, Sinai Hospital of Baltimore, Rubin Institute for Advanced Orthopedics, Baltimore, MD, USA.
  • Department of Orthopaedic Surgery and Rehabilitation Medicine, Downstate Medical Center, State University of New York (SUNY), Brooklyn, NY, USA. Electronic address: qnaziri@gmail.com.

Zitieren

APA

Baksh, N., Nadarajah, V., Connors, K. M., Bains, S. S., Chen, Z., Dubin, J. A., & Naziri, Q. (2023). Does preoperative corticosteroid injection increase the risk of periprosthetic joint infection after reverse shoulder arthroplasty?. Journal of Shoulder and Elbow Surgery. https://doi.org/10.1016/j.jse.2023.01.008

Vancouver

Baksh N, Nadarajah V, Connors KM, Bains SS, Chen Z, Dubin JA, et al. Does preoperative corticosteroid injection increase the risk of periprosthetic joint infection after reverse shoulder arthroplasty?. Journal of Shoulder and Elbow Surgery. 2023. doi:10.1016/j.jse.2023.01.008

BibTeX
@article{Baksh2023,
  author = {Baksh, Nayeem and Nadarajah, Vidushan and Connors, Katherine M and Bains, Sandeep S and Chen, Zhongming and Dubin, Jeremy A and Naziri, Qais},
  title = {Does preoperative corticosteroid injection increase the risk of periprosthetic joint infection after reverse shoulder arthroplasty?},
  journal = {Journal of Shoulder and Elbow Surgery},
  year = {2023},
  doi = {10.1016/j.jse.2023.01.008}
}
Kostenlos starten →